MinION gene reading tool to find germs in diabetic foot bone infection
Compares MinION with routine lab culture for finding germs in diabetic foot bone infection.
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Nīmes
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis
- Status
- Recruiting
- People taking part
- 43 people, planned
- Started
- 12 Feb 2026
- Expected to end
- Dec 2027
- Type of study
- Observational
- Record updated
- 13 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with diabetes who have a bone infection in the foot (diabetic foot osteomyelitis). It compares a new test (MinION) with routine lab culture on bone samples.
- Sex
- All sexes can join.
- Disease stage
- Diabetic foot osteomyelitis, a bone infection under a foot wound.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- N/A
Who cannot take part
- N/A
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Diabetic foot wound infections are predominantly polymicrobial. However, 'conventional' microbiological culture does not identify all the bacteria potentially involved in these infections and requires time, which can have a negative impact by delaying treatment and/or the prescription of appropriate antibiotic therapy.
Read full original descriptionShow less
Real-time metagenomics analysis using Oxford Nanopore Technologies' MinION technology has demonstrated sufficient power to identify virtually all microbial genomes in a given sample, providing additional information on their antibiotic resistance profile and in silico prediction of genes encoding virulence factors within than 4 hours. Based on these rapid results, a management protocol could be defined specifically for each patient with a view to personalised medicine.
The aim is to study the diversity of bacterial and fungal species identified using the MinION method and compare this diversity with the results obtained using conventional methods (routine culture) from bone biopsies taken from DFOM patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of a New Diagnostic Tool (MinION) for Identifying Microorganisms in the Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis (DFOM)
- Plain-language title
- MinION gene reading tool to find germs in diabetic foot bone infectionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 13 November 2026